Trials / Completed
CompletedNCT04296045
A Study to Investigate the Effect of MCE on Glucose and Insulin Responses in Healthy Males
A Randomised, Double-blind, Placebo-controlled, Cross-over Study, to Investigate the Effect of Maize Cob Extract on Post-prandial Glucose and Insulin Responses in Healthy Males
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Cambridge Glycoscience · Industry
- Sex
- Male
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Maize Cob Extract (MCE) is intended to be used as a bulking agent in food. The purpose of this study is to determine the glycaemic and insulinemic response of MCE consumed in isolation compared to glucose; the glycaemic and insulinemic response will also be determined for MCE alone and in combination with glucose. This is a randomised, double-blind, single-centre trial in 10 healthy male participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | MCE | Ingestion of 15g MCE in water after min 10 hours of fasting |
| DIETARY_SUPPLEMENT | Glucose | Ingestion of 15g glucose in water after min 10 hours of fasting |
Timeline
- Start date
- 2020-07-02
- Primary completion
- 2020-07-31
- Completion
- 2020-08-28
- First posted
- 2020-03-05
- Last updated
- 2022-10-19
Locations
1 site across 1 country: Ireland
Source: ClinicalTrials.gov record NCT04296045. Inclusion in this directory is not an endorsement.